INN: fexofenadine
Pharmacotherapeutic group: antiallergic agent - H1-histamine receptor blocker
Indications for use

• Seasonal allergic rhinitis (120 mg tablets).
• Chronic idiopathic urticaria (to reduce symptoms) (180 mg tablets).

Contraindications

Hypersensitivity to any of the components of the drug; lactase deficiency, lactose intolerance, glucose-galactose malabsorption; children up to 12 years; pregnancy and breastfeeding period.

Carefully

Chronic renal failure, liver failure, advanced age, cardiovascular diseases (in history).
Use during pregnancy and during breastfeeding
The use of the drug Fexofenadine-Akrihin is contraindicated during pregnancy and during breastfeeding.

Dosage and administration

Inside, adults and children over 12 years old.
With seasonal allergic rhinitis, the recommended dose is 120 mg 1 time per day before meals.
In chronic idiopathic urticaria (to reduce symptoms), the recommended dose is 180 mg once a day before meals.

Side effect

The frequency of side effects is classified according to the recommendations of the World Health Organization (WHO): very often (≥ 10%); often (≥ 1%, <10%); infrequently (≥ 0.1%, <1%); rarely (> 0.01%, <0.1%); very rarely (<0.01%),including isolated cases.
On the part of the nervous system: often - headache, drowsiness, dizziness.
On the part of the gastrointestinal tract: often - nausea.
On the part of the skin and subcutaneous tissues: rarely - rash.
Others: often - fatigue; infrequently - weakness.
Post-marketing research (frequency unknown)
On the part of the immune system: hypersensitivity reactions (angioedema, difficulty breathing, shortness of breath, skin hyperemia, systemic anaphylactic reactions).
From the nervous system and psyche: insomnia, nervousness, sleep disturbance, nightmares.
Since the cardiovascular system: tachycardia, palpitations.
From the gastrointestinal tract: diarrhea.
On the part of the skin and subcutaneous tissues: rash, hives, itching.

Release form

Tablets, film coated, 120 mg and 180 mg.
On 10 pills in a blister strip packaging from a film of polyvinyl chloride and aluminum foil.
1 or 3 blister packs for pills with a dosage of 120 mg or 1 blister packs for pills with a dosage of 180 mg together with instructions for use are placed in a pack of cardboard.

Storage conditions

In a dry, dark place at a temperature not higher than 25 ° C.
Keep out of the reach of children.

Vacation conditions

Over the counter